Citurgia Biochemicals board meeting scheduled for May 30, 2026 to approve audited standalone financial results for Q4 and FY ended March 31, 2026.
Trading window closure for insiders effective from April 1, 2026, with reopening 48 hours after results declaration.
Disclosure made pursuant to SEBI LODR Regulation 29 for mandatory corporate announcements.